Publication Name	World Journal of Critical Care Medicine
Manuscript ID	96877
Country	United States

Received	2024-05-17 02:33
Peer-Review Started	2024-05-17 02:33
To Make the First Decision
Return for Revision	2024-06-19 06:12
Revised	2024-06-28 21:03
Second Decision	2024-07-17 02:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-07-17 10:02
Articles in Press	2024-07-17 10:02
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-07-25 07:36
Publish the Manuscript Online	2024-08-30 06:01

ISSN	2220-3141(online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Critical Care Medicine
Manuscript Type	Minireviews
Article Title	Remimazolam in intensive care unit: Potential applications and considerations
Manuscript Source	Invited Manuscript
All Author List	Praveen Reddy Elmati, Teja Nagaradona, Gowthami Sai Kogilathota Jagirdhar and Salim Surani
ORCID	Author(s) ORCID Number Praveen Reddy Elmati http://orcid.org/0000-0003-1283-2368 Gowthami Sai Kogilathota Jagirdhar http://orcid.org/0000-0003-1855-0863 Salim Surani http://orcid.org/0000-0001-7105-4266
Funding Agency and Grant Number
Corresponding Author	Salim Surani, FCCP, MD, MS, Professor, Department of Medicine & Pharmacology, Texas A&M University, 40 Bizzell Street, College Station, TX 77843, United States. srsurani@hotmail.com
Key Words	Remimazolam; Intensive care; Critical care; Anesthesia; Sedation; Mechanical ventilation; Benzodiazepine
Core Tip	Remimazolam, an ultra-short-acting benzodiazepine, offers rapid onset, stable hemodynamics, and organ-independent metabolism, ideal for intensive care unit sedation and procedural anesthesia. Its advantages over traditional sedatives like midazolam and propofol include faster recovery, reduced hemodynamic instability, and a favorable safety profile. Remimazolam is effective for sedation in hemodynamically unstable patients and those with hepatic or renal impairment, highlighting its potential for broader clinical application. Further research is necessary to establish guidelines for its routine use.
Publish Date	2024-08-30 06:01
Citation	<p>Elmati PR, Nagaradona T, Jagirdhar GSK, Surani S. Remimazolam in intensive care unit: Potential applications and considerations. <i>World J Crit Care Med</i> 2024; 13(3): 96877</p>
URL	https://www.wjgnet.com/2220-3141/full/v13/i3/96877.htm
DOI	https://dx.doi.org/10.5492/wjccm.v13.i3.96877

Full Article (PDF)	WJCCM-13-96877-with-cover.pdf
Manuscript File	96877_Auto_Edited_011805.docx
Answering Reviewers	96877-answering-reviewers.pdf
Audio Core Tip	96877-audio.mp3
Conflict-of-Interest Disclosure Form	96877-conflict-of-interest-statement.pdf
Copyright License Agreement	96877-copyright-assignment.pdf
Peer-review Report	96877-peer-reviews.pdf
Scientific Misconduct Check	96877-scientific-misconduct-check.png
Scientific Editor Work List	96877-scientific-editor-work-list.pdf
CrossCheck Report	96877-crosscheck-report.pdf
CrossCheck Report	96877-crosscheck-report.png